Protagonist Therapeutics PTGX Business Segments — Income Tax Expense Benefit

Similar metrics at other companies

DGSingle Reportable — Income Tax Expense Benefit

$147.15M+23.1%

ONTOSingle Reportable — Income Tax Expense Benefit

$6.54M+39.2%

LQD

LQDASingle Reportable — Income Tax Expense Benefit

$3.92M—

RMBSReportable — Income Tax Expense Benefit

$8.77M+19.8%

NFLXReportable Segment — Income Tax Expense (Benefit)

$1.26B+291%

PNW

PNWReportable Segment — Income Tax Expense (Benefit)

-$1M-117%

Questions, answered.

What is Protagonist Therapeutics's business segments — income tax expense benefit?

Protagonist Therapeutics (PTGX) reported business segments — income tax expense benefit of -$1.5M in Q1 2026.

What does business segments — income tax expense benefit mean?

This metric represents the total income tax expense or benefit recognized by the business segment during the reporting period. It reflects the tax implications of the segment's operational profitability and regulatory environment, providing insight into the net tax impact on the segment's financial performance. Investors use this to understand the effective tax burden associated with the segment's specific activities and jurisdictional operations.